Clinical Trials Logo

Filter by:
NCT ID: NCT05561699 Not yet recruiting - Clinical trials for Esophageal Squamous Cell Carcinoma

Sequential Preoperative Penpulimab Combined With Chemoradiotherapy(CRT) for Locally Advanced Esophageal Squamous Cell Cancer

SPEED
Start date: September 28, 2022
Phase: N/A
Study type: Interventional

This study used an open single center study design to observe the efficacy and safety of Penpulimab combined with Chemoradiotherapy(CRT) in preoperative T2,3,4aN0-1-2M0 esophageal squamous cell carcinoma (ESCC).

NCT ID: NCT05561686 Not yet recruiting - Clinical trials for HER2-positive Breast Cancer

Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer

Start date: October 1, 2022
Phase:
Study type: Observational

Pyrotinib is currently being investigated in both registration studies and investigator-initiated studies in the neoadjuvant and adjuvant setting for HER2-positive breast cancer, all of which are RCTs, but randomized clinical studies have selected specific populations in defined settings, which may differ from the actual clinical setting. Given the limited real-world data on pyrotinib, real-world studies focusing on neoadjuvant therapy have not been reported. At present, we hope to collect the data of neoadjuvant therapy for HER2-positive breast cancer patients who have been prescribed pyrotinib, and explore the efficacy and safety of pyrotinib-based neoadjuvant therapy for HER2-positive early or locally advanced breast cancer patients; exploratory analysis to explore the correlation between TMB levels and pCR rate of neoadjuvant therapy in HER2-positive breast cancer patients, and the effect of pyrotinib-based neoadjuvant therapy on intestinal flora.

NCT ID: NCT05560373 Not yet recruiting - Clinical trials for Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage

The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study

Start date: September 30, 2022
Phase: Phase 4
Study type: Interventional

Under the premise of basic treatment, to explore the improvement effect of huperzine A injection on short-term and long-term neurocognitive dysfunction in patients with aneurysmal subarachnoid hemorrhage after interventional/surgical treatment.

NCT ID: NCT05559242 Not yet recruiting - Liver Dysfunction Clinical Trials

Pharmacokinetic Study of Anlotinib Hydrochloride Capsules in Healthy Subjects and Liver Dysfunction Patients

Start date: October 2022
Phase: Phase 1
Study type: Interventional

To evaluate the pharmacokinetic difference of anlotinib hydrochloride capsule between mild/moderate liver dysfunction subjects and healthy subjects, and to provide basis for formulating the clinical drug regimen for patients with liver dysfunction.

NCT ID: NCT05556460 Not yet recruiting - Clinical trials for Tricuspid Regurgitation

Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation

Start date: October 15, 2022
Phase: N/A
Study type: Interventional

To confirm the effectiveness and safety of the DragonFly-T transcatheter tricuspid valve repair system for the treatment of severe tricuspid regurgitation (TR) (TR grade ≥ 3+) who remained clinically symptomatic after guideline-directed medical treatment.

NCT ID: NCT05553626 Not yet recruiting - Heart Failure Clinical Trials

Safety and Effectiveness of Left Bundle Branch Pacing in Patients With Cardiac Dysfunction and AV Block

Start date: September 2022
Phase: N/A
Study type: Interventional

This study is a multicenter, prospective, randomized study to assess if cardiac dysfunction patients with LVEF <50% and the estimated ventricular pacing percentage >40% with LBBP have the non-inferior safety and efficacy than CRT on patients' cardiac function and prognosis

NCT ID: NCT05552729 Not yet recruiting - Clinical trials for Cognitive Impairment

Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors

Start date: September 22, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

To explore the effect of different doses of vitamin D drugs on gastrointestinal cancer cancer-related cognitive impairment, so as to provide reference and basis for the clinical use of our cognitive function surgery nursing plan for patients with gastrointestinal cancer.

NCT ID: NCT05550740 Not yet recruiting - Eye Diseases Clinical Trials

Repeated Low-Level Red-Light Therapy for Shortening Axial Length

Start date: October 22, 2022
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to confirm the incidence and magnitude of axial length shortening after RLRL therapy in Chinese high myopia children and teenagers.

NCT ID: NCT05550012 Not yet recruiting - Deep Learning Clinical Trials

A New Deep-learning Based Artificial Intelligence Iterative Reconstruction (AIIR) Algorithm in Low-dose Liver CT

Start date: September 30, 2022
Phase: N/A
Study type: Interventional

CT-enhanced scans are routine imaging modality for the diagnosis and follow-up of liver disease. However, this means that patients will receive more radiation dose. Therefore, it is necessary to reduce the radiation dose received by patients as much as possible. Deep learning-based reconstruction algorithms have been introduced to improve image quality recently. For many years, researchers attempt to maintain image quality using an advanced method while reducing radiation dose. Recently, a new deep-learning based iterative reconstruction algorithm, namely artificial intelligence iterative reconstruction (AIIR, United Imaging Healthcare, Shanghai, China) has been introduced. In this study, we evaluate the image and diagnostic qualities of AIIR for low-dose portal vein and delayed phase liver CT with those of a KARL method normally used in standard-dose CT.

NCT ID: NCT05547516 Not yet recruiting - Clinical trials for Non-muscle-invasive Bladder Cancer

Blue Laser -5ala Photodynamic Therapy (PDT) in High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

BL-PDT-RCT
Start date: September 13, 2022
Phase: N/A
Study type: Interventional

This project will conduct a large-sample, multi-center prospective clinical trial to further establish the safety and efficacy of BL-5ALA-PDT in preventing Non-Muscle Invasive Bladder Cancer (NMIBC) recurrence when compared to the usual postoperative perfusion chemotherapy regimen.